CMS indicated it might re-examine its testing policies at an ICD-10 stakeholder collaboration meeting, Robert Tennant, senior policy adviser of Medical Group Management Association, told MedPage Today.
Earlier this year, MGMA urged the agency to conduct end-to-end testing with external partners. MGMA President and CEO Susan Turney, MD, wrote in a letter to HHS Secretary Kathleen Sebelius that failure to carry out external testing could result in a “catastrophic” backlog of Medicare claims following the October 2014 implementation deadline.
CMS did not respond to questions about whether it was reconsidering its ICD-10 testing policies in light of the part improper testing played in the glitch-ridden rollout of HealthCare.gov, according to the report.
More Articles on ICD-10:
Report: Only 63% of ICD-10 Documentation Accurately Coded
ICD-10 Prep Work: Why Hospitals Need to Reach Out to Payers
End-to-End Testing for ICD-10: A Primer for Healthcare Executives
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
